Lee Lindley

Lee Lindley is a dedicated venture capital investor with Mercia Ventures, specializing in Life Sciences, HealthTech, and DeepTech sectors. He focuses on identifying, completing, and supporting investments in novel products and technologies, particularly those addressing clear problems and adding significant value. co+2

With a strong background in science (Natural Sciences from Cambridge and MRes in Research Methods from Manchester), Lee bridges the gap between scientific innovation and commercial success. His scientific training allows him to effectively work with scientists and engineers to bring their innovations to market. co+1

Before joining Mercia Ventures, Lee spent seven years in Corporate Finance at PwC, advising on M&A transactions and growth equity raises across various sectors, including healthcare, telecoms, transport, digital infrastructure, and energy. This experience, combined with his qualification as a Chartered Management Accountant, provides him with a robust understanding of financial dynamics and business strategy. co+1

Lee actively serves as an Investor and Non-Executive Director for several portfolio companies, including Scalpel, Wobble Genomics, Camena Bioscience, and Sen, demonstrating his hands-on involvement and commitment to supporting early-stage companies in the deep tech and life sciences space. crunchbase+1

He is keenly aware of market dynamics in venture capital, particularly the changing landscape of valuations and the increased emphasis on efficient capital deployment and demonstrated progress for startups seeking funding, as highlighted in his podcast appearances. youtube